Woodstock Corp Sells 100 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Woodstock Corp cut its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 12.8% during the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 684 shares of the healthcare conglomerate’s stock after selling 100 shares during the quarter. Woodstock Corp’s holdings in UnitedHealth Group were worth $338,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds also recently made changes to their positions in UNH. Texas Capital Bancshares Inc TX boosted its stake in shares of UnitedHealth Group by 1.1% in the 3rd quarter. Texas Capital Bancshares Inc TX now owns 1,695 shares of the healthcare conglomerate’s stock valued at $855,000 after purchasing an additional 19 shares during the last quarter. Tealwood Asset Management Inc. grew its holdings in UnitedHealth Group by 0.4% during the 4th quarter. Tealwood Asset Management Inc. now owns 4,988 shares of the healthcare conglomerate’s stock worth $2,626,000 after acquiring an additional 19 shares during the period. Atlas Private Wealth Advisors lifted its stake in shares of UnitedHealth Group by 1.1% in the 4th quarter. Atlas Private Wealth Advisors now owns 1,752 shares of the healthcare conglomerate’s stock valued at $923,000 after purchasing an additional 19 shares during the period. Prentice Wealth Management LLC grew its stake in UnitedHealth Group by 0.8% during the fourth quarter. Prentice Wealth Management LLC now owns 2,347 shares of the healthcare conglomerate’s stock worth $1,235,000 after purchasing an additional 19 shares during the period. Finally, Baker Avenue Asset Management LP lifted its stake in UnitedHealth Group by 1.7% in the third quarter. Baker Avenue Asset Management LP now owns 1,219 shares of the healthcare conglomerate’s stock valued at $615,000 after buying an additional 20 shares during the period. Institutional investors and hedge funds own 87.86% of the company’s stock.

UnitedHealth Group Price Performance

Shares of NYSE:UNH opened at $484.62 on Friday. The company has a market capitalization of $446.04 billion, a P/E ratio of 29.62, a price-to-earnings-growth ratio of 1.40 and a beta of 0.58. The company has a debt-to-equity ratio of 0.69, a quick ratio of 0.85 and a current ratio of 0.85. UnitedHealth Group Incorporated has a fifty-two week low of $436.38 and a fifty-two week high of $554.70. The company’s 50-day moving average is $496.12 and its 200 day moving average is $504.71.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings results on Tuesday, April 16th. The healthcare conglomerate reported $6.91 EPS for the quarter, topping analysts’ consensus estimates of $6.63 by $0.28. UnitedHealth Group had a net margin of 4.05% and a return on equity of 26.50%. The company had revenue of $99.80 billion for the quarter, compared to analysts’ expectations of $99.23 billion. During the same quarter in the previous year, the firm posted $6.26 EPS. UnitedHealth Group’s revenue was up 8.6% on a year-over-year basis. On average, equities research analysts forecast that UnitedHealth Group Incorporated will post 27.57 earnings per share for the current year.

UnitedHealth Group Increases Dividend

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, June 25th. Investors of record on Monday, June 17th will be paid a dividend of $2.10 per share. This is a boost from UnitedHealth Group’s previous quarterly dividend of $1.88. This represents a $8.40 dividend on an annualized basis and a dividend yield of 1.73%. The ex-dividend date of this dividend is Monday, June 17th. UnitedHealth Group’s dividend payout ratio is presently 51.34%.

Analyst Upgrades and Downgrades

A number of research analysts recently issued reports on the stock. TD Cowen dropped their target price on shares of UnitedHealth Group from $607.00 to $546.00 and set a “buy” rating on the stock in a research report on Wednesday, April 10th. Baird R W upgraded UnitedHealth Group to a “strong-buy” rating in a research note on Thursday, May 30th. HSBC upgraded UnitedHealth Group from a “hold” rating to a “buy” rating and set a $580.00 price target on the stock in a report on Wednesday, June 5th. Truist Financial restated a “buy” rating and set a $600.00 price objective on shares of UnitedHealth Group in a report on Wednesday, April 17th. Finally, StockNews.com lowered shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a research note on Thursday. Three analysts have rated the stock with a hold rating, seventeen have given a buy rating and one has issued a strong buy rating to the company. Based on data from MarketBeat.com, UnitedHealth Group presently has a consensus rating of “Moderate Buy” and an average price target of $579.74.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.